Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02690220
Other study ID # pfm15k001 TiLOOP® PRO A
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2016
Est. completion date July 31, 2017

Study information

Verified date January 2019
Source pfm medical ag
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the influence of anterior pelvic prolapse reconstruction with a titanized polypropylene mesh on patients quality of life.


Description:

This multicentre, non-randomized, observational clinical investigation will be performed to obtain usability and postmarket information on the TiLOOP® pelvic floor reconstruction meshes and in particular to obtain the improvement of patients' quality of life.

It is expected that the patient's quality of life is meliorated after implantation of a TiLOOP® PRO A mesh. To verify this, it will be shown that by means of a validated questionnaire the subjective quality of life after 12 months is significantly better than before implantation.


Recruitment information / eligibility

Status Completed
Enrollment 54
Est. completion date July 31, 2017
Est. primary completion date July 31, 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Existence of a cystocele. Women with a symptomatic genital descensus: at least stage II (ICS-classification according POP-Q system). This applies to primary as well as recurrent intervention.

2. Patient is mentally able to understand the nature, aims, or possible consequences of the clinical investigation.

3. Patient information has been handed out and written consent is at hand.

4. Patient has attained full age (18 years or older).

Exclusion Criteria:

1. Unfinished family planning, pregnancy or breast-feeding mother.

2. Known intolerance to the mesh-implants under investigation.

3. Lack of written patients' informed consent.

4. Lack of patient compliance regarding data collection, treatment or follow-up investigations in the scope of the protocol.

5. Patients with acute (within the last 12 months) carcinoma in the pelvic area.

6. Patients with history of radiotherapy in the pelvic area.

7. Patients with implanted anterior pelvic floor mesh.

8. Patient is institutionalized by court or official order (MPG §20.3).

9. Participation in another interventional clinical investigation.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
TiLOOP® PRO Plus A
The standard operation method for the surgical repair of anterior prolapse is via the obturator membrane. The mesh is placed trans-vaginally using the TiLOOP® Application Set to place the mesh arms.

Locations

Country Name City State
Germany Klinikum Augsburg Augsburg Bayern
Germany Klinikum Dresden-Friedrichstadt Dresden Sachsen
Germany Ev. Amalie-Sieveking-Krankenhaus Hamburg
Germany Klinik Tettnang GmbH Tettnang Baden-Württemberg
Germany Klinikum Oberlausitzer Bergland gemeinnützige GmbH Zittau Sachsen

Sponsors (4)

Lead Sponsor Collaborator
pfm medical ag Aix Scientifics, Bayes GmbH, Crolll Gmbh

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Cadenbach-Blome T, Grebe M, Mengel M, Pauli F, Greser A, Fünfgeld C. Significant Improvement in Quality of Life, Positive Effect on Sexuality, Lasting Reconstructive Result and Low Rate of Complications Following Cystocele Correction Using a Lightweight, Large-Pore, Titanised Polypropylene Mesh: Final Results of a National, Multicentre Observational Study. Geburtshilfe Frauenheilkd. 2019 Sep;79(9):959-968. doi: 10.1055/a-0984-6614. Epub 2019 Sep 11. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Patient's Quality of Life By means of a validated questionnaire it will be shown whether the subjective quality of life after 12 months is significantly better than before implantation. 12 months
Secondary Patient's Quality of Life The evaluation of changes in quality of life assessed by the P-QoL 6 months after implantation of the TiLOOP® PRO A surgical mesh compared to before implantation. 6 months
Secondary Adverse Events (AE) Assessment and analysis of all [serious] adverse events ([S]AEs) during the first 12 months after implantation along with a contextual placement of safety data based on current literature. 6 weeks, 6 and 12 months
Secondary Feasibility Check of Mesh implantation To evaluate mesh implantation, information about the duration of the procedure (minutes from cut to stitches) and the operability of the application set (easy, suitable, difficult, no set used) will be collected during the surgery. Taking together, this information will encapsulate the feasibility of the mesh implantation descriptively. 1 day
Secondary Number of complications and concomitant procedures Counting the number of intraoperative complications (e. g. lesion of the bladder, the urethra or the intestines) and concomitant procedures (e. g. hysterectomy, colporrhaphy, vaginal sacrospinal fixation) procedure-related adverse events as assessed by CTCAE v4.0 and common concomitant procedures will be evaluated. 1 day
See also
  Status Clinical Trial Phase
Completed NCT01637441 - Prosthetic Pelvic Organ Prolapse Repair N/A
Recruiting NCT04009694 - Does a High BMI Affect Supervised Pelvic Floor Muscle Training for Improving Symptoms in Women With Various Stages of Pelvic Organ Prolapse? N/A
Completed NCT04481906 - Vaginal Mesh Procedures for Female Cystocele
Completed NCT02888093 - A Randomized Controlled Trial of Permanent vs Absorbable Suture for Uterosacral Ligament Suspension N/A
Completed NCT02255994 - UGYTEX® Mesh Versus Subvesical Plication in the Surgical Treatment of Bladder Prolapse N/A
Completed NCT02272361 - Trial Comparing Laparoscopic Sacropexy and Vaginal Mesh Surgery for Women Cystocele Repair. N/A
Withdrawn NCT00942474 - Nerve Access Tool Study N/A
Completed NCT04417413 - Safety and Efficacy of Non-ablative Er:YAG Laser Therapy for the Treatment of Pelvic Organ Prolapse and Coexisting Stress Urinary Incontinence: A Retrospective Case Series.
Active, not recruiting NCT03714607 - Laser Therapy in Managing Vaginal Prolapse N/A
Completed NCT04184128 - Detrusor Underactivity and Bladder Outlet Obstruction in Women With Cystocele
Active, not recruiting NCT01097200 - Sacrocolpopexy Versus Vaginal Mesh Procedure for Pelvic Prolapse N/A
Recruiting NCT00162604 - Prophylactic Antibiotic Treatment During Vaginal Repair N/A
Completed NCT02400034 - Comparing Voiding Trials After Midurethral Sling for Stress Incontinence N/A
Completed NCT01559558 - Changes of Pad Weight Results and Urethral Pressure Profiles After Reduction of Cystocele by Vaginal Gauze Packing N/A
Not yet recruiting NCT03056586 - The Effect of Pessary Post Vaginal Prolapse Repair, for One Month, to Reduce the Recurrence Rate of Prolapse N/A
Active, not recruiting NCT02272322 - Transvaginal Treatment of Symptomatic Cystocele Grade II-III N/A
Completed NCT00557882 - Efficacy Study of Vaginal Mesh for Anterior Prolapse Phase 4
Completed NCT06410469 - A Novel Suturing Technique of Cystocele Treatment
Completed NCT04175782 - Enhanced Recovery Protocol in Urogynecologic Surgery N/A
Recruiting NCT05449054 - Continuous Stitches Versus Simple Interrupted Stitches for Anterior Colporrhaphy N/A